Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal

NCT03887871 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: Harnal-D Tab.
DRUG: Chong Kun Dang Tamsulosin HCl Tab.

Sponsor

Chong Kun Dang Pharmaceutical